Australia
· Delayed Price · Currency is AUD Vitasora Health Statistics
Total Valuation
Vitasora Health has a market cap or net worth of AUD 59.86 million. The enterprise value is 58.70 million.
| Market Cap | 59.86M |
| Enterprise Value | 58.70M |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitasora Health has 1.58 billion shares outstanding. The number of shares has increased by 34.76% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.58B |
| Shares Change (YoY) | +34.76% |
| Shares Change (QoQ) | +7.35% |
| Owned by Insiders (%) | 9.70% |
| Owned by Institutions (%) | 8.20% |
| Float | 1.22B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.29 |
| PB Ratio | 12.43 |
| P/TBV Ratio | 21.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.74 |
| EV / Sales | 31.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.82 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.28 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -4,255.79 |
Financial Efficiency
Return on equity (ROE) is -181.82% and return on invested capital (ROIC) is -110.90%.
| Return on Equity (ROE) | -181.82% |
| Return on Assets (ROA) | -71.04% |
| Return on Invested Capital (ROIC) | -110.90% |
| Return on Capital Employed (ROCE) | -154.25% |
| Revenue Per Employee | 61,790 |
| Profits Per Employee | -252,711 |
| Employee Count | 30 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.42 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,059,405 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitasora Health had revenue of AUD 1.85 million and -7.58 million in losses. Loss per share was -0.01.
| Revenue | 1.85M |
| Gross Profit | 1.55M |
| Operating Income | -7.58M |
| Pretax Income | -7.58M |
| Net Income | -7.58M |
| EBITDA | -7.62M |
| EBIT | -7.58M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.25 million in cash and 87,372 in debt, giving a net cash position of 1.16 million or 0.00 per share.
| Cash & Cash Equivalents | 1.25M |
| Total Debt | 87,372 |
| Net Cash | 1.16M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.82M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.78M |
Cash Flow
In the last 12 months, operating cash flow was -7.51 million and capital expenditures 10,107, giving a free cash flow of -7.50 million.
| Operating Cash Flow | -7.51M |
| Capital Expenditures | 10,107 |
| Free Cash Flow | -7.50M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 83.63% |
| Operating Margin | -408.89% |
| Pretax Margin | -408.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vitasora Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.76% |
| Shareholder Yield | -34.76% |
| Earnings Yield | -12.67% |
| FCF Yield | -12.53% |
Stock Splits
The last stock split was on July 31, 2012. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 31, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Vitasora Health has an Altman Z-Score of -18.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.54 |
| Piotroski F-Score | n/a |